| FARN Stock | | | 172.50 2.50 1.47% |
Faron Pharmaceuticals financial indicator trend analysis is much more than just examining Faron Pharmaceuticals latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Faron Pharmaceuticals is a good investment. Please check the relationship between Faron Pharmaceuticals Change To Inventory and its End Period Cash Flow accounts. Check out
Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Faron Pharmaceuticals Oy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
Change To Inventory vs End Period Cash Flow
Change To Inventory vs End Period Cash Flow Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Faron Pharmaceuticals Change To Inventory account and
End Period Cash Flow. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Faron Pharmaceuticals' Change To Inventory and End Period Cash Flow is -0.56. Overlapping area represents the amount of variation of Change To Inventory that can explain the historical movement of End Period Cash Flow in the same time period over historical financial statements of Faron Pharmaceuticals Oy, assuming nothing else is changed. The correlation between historical values of Faron Pharmaceuticals' Change To Inventory and End Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Change To Inventory of Faron Pharmaceuticals Oy are associated (or correlated) with its End Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when End Period Cash Flow has no effect on the direction of Change To Inventory i.e., Faron Pharmaceuticals' Change To Inventory and End Period Cash Flow go up and down completely randomly.
Correlation Coefficient | -0.56 |
| Relationship Direction | Negative |
| Relationship Strength | Very Weak |
Change To Inventory
The increase or decrease in the amount of inventory a company has over a certain period.
End Period Cash Flow
Most indicators from Faron Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Faron Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Faron Pharmaceuticals Oy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
Selling General Administrative is likely to gain to about 9.1
M in 2024, whereas
Tax Provision is likely to drop 0.00 in 2024.
Faron Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Faron Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Faron Pharmaceuticals fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Faron Stock Analysis
When running Faron Pharmaceuticals' price analysis, check to
measure Faron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Faron Pharmaceuticals is operating at the current time. Most of Faron Pharmaceuticals' value examination focuses on studying past and present price action to
predict the probability of Faron Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Faron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Faron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.